Alefacept is a genetically engineered immunosuppressive drug. It was sold under the brand name Amevive in Canada, the United States, Israel, Switzerland...
11 KB (1,240 words) - 03:41, 23 August 2022
cyclophosphamide, mycophenolate, intravenous immunoglobulin, rituximab, sirolimus, alefacept, and the tyrosine kinase inhibitors, imatinib, nilotinib, and dasatinib...
38 KB (3,293 words) - 18:29, 29 August 2024
(amphotericin B) – Anti-fungal – marketed with Gilead Sciences. Amevive (alefacept) – plaque psoriasis Astagraf XL (tacrolimus) – Prevention of post-transplant...
27 KB (2,460 words) - 00:25, 13 September 2024
ulcerative colitis, Crohn's disease monoclonal antibody TNF antagonist alefacept Amevive chronic plaque psoriasis immunoglobin G1 fusion protein incompletely...
30 KB (2,882 words) - 11:11, 23 July 2024
Antibodies -cept (Fusion) CTLA-4 Abatacept Belatacept TNF inhibitor Etanercept Opinercept Aflibercept Alefacept Rilonacept...
7 KB (299 words) - 13:45, 27 April 2024
Antithymocyte immunoglobulin (rabbit) L04AA06 Mycophenolic acid L04AA15 Alefacept L04AA19 Gusperimus L04AA22 Abetimus L04AA24 Abatacept L04AA28 Belatacept...
3 KB (367 words) - 15:37, 25 January 2024
thalidomide, etretinate, cyclosporine and, most recently, intramuscular alefacept may control the disease but are ineffective for severe chronic or relapsing...
9 KB (877 words) - 19:53, 23 August 2024
adverse effects. Two medications that target T cells are efalizumab and alefacept. Efalizumab is a monoclonal antibody that specifically targets the CD11a...
116 KB (13,059 words) - 13:20, 22 September 2024
IL-1 receptors to treat cryopyrin-associated periodic syndromes (CAPS). Alefacept: Regulated T-cell responses by selectively targeting effector memory T-cells...
19 KB (2,305 words) - 05:22, 15 May 2024
(INN) Aldoclor Aldomet Aldoril aldosterone (INN) Aldurazyme Alecensa alefacept (USAN) aleglitazar (USAN, INN) alemtuzumab (INN) alendronic acid (INN)...
12 KB (566 words) - 20:37, 27 August 2024